Who Can Administer Emergency Medication for Seizures?

Emergency seizure medications can be administered by a surprisingly wide range of people, not just doctors or paramedics. Family members, school staff, residential care workers, camp counselors, and in some cases the person having the seizure can all deliver these drugs, provided they have appropriate training and a prescriber’s authorization. The key factor is not a medical license but rather the medication’s route of delivery: newer nasal sprays and buccal (inside-the-cheek) formulations were specifically designed so that non-medical personnel could use them safely outside a hospital. Understanding who is allowed and able to give these medications, and under what circumstances, can mean the difference between a seizure that resolves quickly and one that escalates into a medical emergency.

Why the Route of Delivery Matters So Much

Three rescue therapies are currently approved in the United States for treating seizure clusters: diazepam rectal gel, midazolam nasal spray, and diazepam nasal spray.¹ The FDA approved intranasal midazolam in 2019 for people aged 12 and older, and intranasal diazepam in 2020 for those aged 6 and older.² Off-label options like sublingual lorazepam and buccal midazolam are also widely used in practice.

The reason route matters for the “who can give it” question is practical. Intravenous medication requires finding a vein, managing an IV line, and monitoring for complications in real time. That is squarely in the territory of trained medical professionals. But intranasal and buccal formulations do not require specialized training and are easier for staff at all levels compared with intravenous treatment.³ Rectal diazepam gel, the oldest approved rescue therapy, involves more steps, including positioning the patient on their side and ensuring the medication is delivered properly. The intranasal routes have fewer steps, focusing mainly on proper handling of the device to get the drug into the nasal passage.³ This simplicity is what opens the door for non-medical people to administer them.

Family Members and Caregivers at Home

The most common scenario for out-of-hospital seizure rescue is a family member giving the medication at home. In one study of sublingual lorazepam used as rescue therapy, family caregivers administered the drug in 88% of cases.⁴ That is not a quirk of one study; it reflects the reality that seizures happen at home more than anywhere else, and family members are the ones present. A prescribing physician writes a seizure action plan that specifies the medication, the dose, and the circumstances under which a caregiver should give it. The caregiver then receives training on how to use the specific device or formulation.

Caregiver preference plays a real role in how well this works. When parents were asked to compare intranasal midazolam with rectal diazepam, those with a preference overwhelmingly favored intranasal midazolam, finding it easier to use and more effective. About 68-74% rated it easier to administer, and 87% perceived it as more effective.⁵ That perception matters because a caregiver who feels confident is more likely to act quickly, and speed is the entire point of rescue medication. Rectal diazepam, while effective, creates social discomfort for adolescents and adults that can lead to hesitation or outright avoidance.¹

School Staff and Trained Volunteers

Schools are the second home for children with epilepsy, and the question of who can give seizure medication in that setting has been addressed by legislation in a growing number of states. California’s Seizure Safe Schools Act, for instance, authorizes local educational agencies to designate volunteer personnel to receive initial and annual refresher training regarding the emergency use of anti-seizure medication.⁶ These volunteers do not need to be nurses. They are typically teachers, aides, or administrators who agree to undergo specific training.

Research on school-based seizure training shows it works. Rectal diazepam gel has been shown to be safe and effective when administered by trained nonmedical school personnel, and its use in schools reduces both the time to treatment and the need for emergency department visits.⁷ A study of school staff in Northern Italy found that those who received seizure-specific training scored significantly higher on knowledge assessments and reported far greater confidence. About 63% of trained staff reported high confidence in administering rescue medication, compared with just 10% of untrained staff.⁸

A large-scale e-learning program in Scotland reinforced these findings. Over 24 months, more than 3,200 learners accessed a training module on buccal midazolam administration. The pass rate was nearly 99%, and learners from teaching and educational roles reported increased confidence in seizure management. People in non-clinical jobs actually performed slightly better than those in clinical roles on the assessment, which suggests that the barrier to safe administration is training, not medical background.⁹

Residential Care and Long-Term Care Facility Staff

Adults with epilepsy who live in group homes or long-term care facilities depend on direct support professionals for nearly everything, including seizure response. These staff members vary widely in medical training. Some are certified nursing assistants, others have no formal clinical background at all. The shift toward intranasal rescue therapies has been particularly significant in these settings, because the simpler administration process lowers the skill threshold. Intranasal and buccal formulations do not require the patient-positioning steps that rectal diazepam demands, making them more practical in a facility where a staff member may be alone with a resident when a seizure begins.³

The legal framework for delegation in these settings typically mirrors the school model: a physician prescribes the rescue medication, writes a seizure action plan, and the facility trains specific personnel to administer the drug. The specifics vary by state, but the core principle is physician delegation to a trained layperson rather than requiring a nurse on site at all times.

The Role of Seizure Action Plans and Physician Delegation

None of this happens without a prescriber’s involvement. A consensus process involving multiple stakeholders in epilepsy care identified several preferred practices, including the need for rescue therapies and seizure action plans to be considered for all people with epilepsy on an individualized basis.¹⁰ A seizure action plan is the document that ties everything together. It specifies what the seizure looks like for that particular person, when to give the rescue medication, which drug and dose to use, and when to call 911. Without this document, a non-medical person giving a controlled substance to someone else is operating without legal authorization.

The consensus group also emphasized the importance of education about rescue therapies, both for the people taking them and for anyone who might administer them.¹⁰ In practice, this means a neurologist or other prescriber does not just hand over a prescription. They walk the caregiver or school nurse through the device, explain the timing, and review the action plan. Some formulations come with demonstration devices that allow practice without wasting actual medication.

People Who Administer Their Own Rescue Medication

Self-administration might sound counterintuitive for a seizure, since many seizures impair consciousness. But not all seizures do. Some people experience warning signs (auras or focal-aware seizures) before a larger event, and those individuals may be able to treat themselves before losing awareness. In a study of patients using diazepam nasal spray, nearly half administered the drug at the first sign of a seizure, and patients with prodromes, auras, or focal-aware onsets were identified as ideal candidates for self-administration.¹¹ These patients were described as generally higher-functioning, including two children mature enough to manage the device themselves, and more than half had used over 20 doses.

In a separate study of sublingual lorazepam, three patients self-administered the drug successfully. Three others used it to treat auras and prevented seizures from progressing further.⁴ Self-administration is not appropriate for everyone and requires a conversation with the prescribing physician, but for the right candidate it adds a meaningful layer of independence. A nasal spray or a tablet that dissolves under the tongue can be used discreetly in a public setting, which matters for adults managing epilepsy in their professional or social lives.

Camps, Extracurricular Activities, and Other Community Settings

Children and adolescents with epilepsy attend summer camps, sports programs, and after-school activities where neither a parent nor a school nurse is present. The American Academy of Pediatrics has recommended that specific protocols and training be created for the administration of rescue medications by campers, counselors, or other unlicensed providers in camp settings.¹² This recommendation recognizes that excluding children from these experiences because of seizure risk is neither necessary nor desirable, as long as the camp has trained staff and a clear plan.

The practical challenge in these settings is turnover. Camp counselors are seasonal workers, many of them college students. Training has to be short, repeatable, and device-specific. The simplicity of nasal spray formulations is a real advantage here, since the instructional burden is far lighter than teaching someone to administer rectal gel to a child they may have met only days earlier.

Safety Concerns With Non-Medical Administration

The obvious worry about broadening the pool of people who can give seizure medication is safety. All benzodiazepines carry risks including respiratory depression, low blood pressure, and oversedation. These concerns can lead to sub-optimal use, meaning caregivers and first responders sometimes hesitate to give the medication even when it is clearly needed.¹³ Hesitation is itself a safety risk: the longer a seizure goes on, the harder it becomes to stop, and the more likely it is to cause brain injury or escalate into status epilepticus, a life-threatening continuous seizure.

Intranasal midazolam has a good safety profile in community and prehospital use in children.¹⁴ The doses in rescue formulations are calibrated for single-use administration, which limits the risk of overdose compared with drawing up a dose from a vial. Still, seizure action plans should specify what to do after the medication is given, including positioning the person on their side, timing the response, and calling emergency services if the seizure does not stop within a defined window, usually five minutes.

How Different Countries Handle This

The rules around who can administer rescue seizure medication are not universal, and international comparisons reveal interesting differences. A study comparing practices in the UK and Norway found that both countries use buccal midazolam as the first-line rescue medication in the community for prolonged and generalized tonic-clonic seizures. However, Norwegian clinicians had more epilepsy-specific experience, managed larger caseloads of patients on buccal midazolam, prescribed higher doses, and provided training to caregivers on a yearly basis. UK clinicians were more likely to delegate rescue medication prescribing to primary care and reviewed emergency management plans more frequently.¹⁵

These differences matter for families who move between countries or who are comparing their own care to what they read online. A seizure action plan written in one country may not automatically translate to the legal and training frameworks of another. The UK’s practice of delegating prescribing to general practitioners means that rescue medication may be more accessible without a specialist visit, while Norway’s emphasis on specialist oversight and annual retraining might produce more consistently prepared caregivers. Neither model is clearly superior; both aim at the same target of getting medication administered quickly and safely by whoever is closest when a seizure happens.

When Pet Owners Need to Act

The question of who can give emergency seizure medication extends beyond human medicine. Dogs with epilepsy also experience seizure clusters and status epilepticus, and the window for effective treatment is just as narrow. Early administration of rescue medication by pet owners at seizure onset can be life-saving and brain-protecting.¹⁶ Veterinary consensus guidelines recommend oral levetiracetam as a first choice for out-of-hospital use in dogs, with rectal administration as an alternative when a dog cannot take medication by mouth.¹⁷

The parallel to human medicine is striking. Pet owners face the same anxiety about giving emergency medication, the same need for a clear action plan from their veterinarian, and the same benefit from formulations that are easy to administer under stress. Intranasal and rectal options reduce the need for injections, which most pet owners are not comfortable giving to a seizing animal. The training model is also similar: the veterinarian demonstrates the technique, the owner practices, and a written plan specifies the dose, timing, and criteria for seeking emergency veterinary care.

Barriers That Still Exist

Despite the broad range of people who can legally and practically administer seizure rescue medication, significant gaps remain. Many people with epilepsy have never been prescribed a rescue therapy at all, even when their seizure pattern would warrant one. The consensus recommendations emphasize that rescue therapies and seizure action plans should be considered for all people with epilepsy in an individualized manner, which implies that current practice falls short of this goal.¹⁰

Even when a rescue therapy is prescribed, practical barriers persist. Schools may lack a designated trained volunteer. Care facilities may have staff turnover that outpaces retraining schedules. Families may receive the prescription but not the education on when and how to use it. The medication itself can be expensive, and insurance coverage varies. And the lingering fear of causing harm with a benzodiazepine, despite decades of safety data in community settings, still causes people to wait too long before acting. The single most consistent finding across all this research is that the biggest risk is not giving the medication when it is needed, not that it was given by someone without a medical degree.